Jean Marc Tourani

Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study

Jean Louis Lefèbvre, Y. Pointreau, Frédéric Rolland et al. · Journal of Clinical Oncology · 2013 · 418 citations · Full text

Medicine, Oncology, Otolaryngology +16

Matched case‐control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel‐induced onycholysis and cutaneous toxicity of the foot

Florian Scotté, Eugéniu Banu, Jacques Médioni et al. · Cancer · 2008 · 104 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14

Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study

Christian Pfister, Gwénaëlle Gravis, Aude Fléchon et al. · The Lancet Oncology · 2023 · 96 citations

Medicine, Oncology, Pharmacology +14

Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program

Laurence Albigès, Aude Fléchon, Christine Chevreau et al. · European Journal of Cancer · 2020 · 54 citations · Full text

Medicine, Oncology, Pharmacology +17

Epidermal growth factor receptor (EGFR) and KRAS mutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer

David Tougeron, Ulrich Cortes, Aurélie Ferru et al. · Cancer Chemotherapy and Pharmacology · 2013 · 18 citations

Medicine, Oncology, Pharmacology +15